[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.158.169.168. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
May 1994

Ocular Manifestations of Leprosy in a Noninstitutionalized Community in the United States

Author Affiliations

From the Department of Ophthalmology and Visual Sciences, Illinois Eye and Ear Infirmary (Drs Dana, Hochman, Viana, and Sugar), and the Department of Dermatology (Dr Hill), University of Illinois at Chicago College of Medicine; and the Epidemiology and Biostatistics Center, University of Illinois at Chicago School of Public Health (Dr Viana). Dr Dana is now affiliated with the Wills Eye Hospital, Philadelphia, Pa.

Arch Ophthalmol. 1994;112(5):626-629. doi:10.1001/archopht.1994.01090170070025
Abstract

Objective:  Our goal was to delineate the epidemiologic and clinical patterns of ocular leprosy in an outpatient setting in the United States.

Design:  Examinations were performed in 61 consecutive outpatients seen in a Midwestern leprosy clinic.

Patients:  Forty-three male and 18 female patients were examined. The patients' origins included Southeast Asia (24 patients [39%]), Latin America (23 patients [38%]), India (nine patients [15%]), Europe or North America (two patients [3%]), Africa (two patients [3%]), and the Middle East (one patient [2%]).

Results:  Thirty-nine percent of patients were classified as having polar lepromatous leprosy; 18%, borderline lepromatous leprosy; 3%, borderline borderline leprosy; 36%, borderline tuberculoid leprosy; 2%, polar tuberculoid leprosy; and 2%, indeterminate leprosy. Ninety-six percent of patients had a best-corrected visual acuity of 20/40 or better. Ocular findings included madarosis (28 patients [46%]), subconjunctival fibrosis (18 patients [30%]), punctate epithelial keratopathy (17 patients [28%]), posterior subcapsular cataract (10 patients [16%]), corneal hypesthesia (10 patients [16%]), lagophthalmos (seven patients [11%]), corneal pannus (six patients [10%]), entropion (five patients [8%]), prominent or beaded corneal nerves (four patients [7%]), iridocyclitis (four patients [7%]), focal avascular keratitis (three patients [5%]), scleritis (three patients [5%]), interstitial keratitis (two patients [3%]), iris pearls (two patients [3%]), and ocular clofazimine crystals (two patients [3%]). Madarosis, corneal hypesthesia, and posterior subscapsular cataracts were significantly associated with disease duration (P<.05).

Conclusion:  We report herein a relatively low frequency of visual impairment attributable to leprosy in our series compared with that seen among institutionalized leprous patients. However, since 48% of subjects had one or more sight-threatening complications as a result of their disease, a program of regular ophthalmic follow-up is strongly advocated for all patients with leprosy.

References
1.
Binford C, Meyers W, Walsh G.  Leprosy . JAMA . 1982;247:2283-2292.Article
2.
Choyce DP.  Blindness in leprosy . Trop Doct . 1973;3:16-19.
3.
Choyce DP.  Discussion on ocular leprosy . Trans R Soc Trop Med Hyg . 1970;64:43-45.Article
4.
Hobbs HE, Choyce DP.  The blinding lesions of leprosy . Lepr Rev . 1971;42:131-137.
5.
Browne SG.  Leprosy (Hansen's disease) . In: Maddin S, ed. Current Dermatologic Therapy . Philadelphia, Pa: WB Saunders Co; 1982:272-277.
6.
Centers for Disease Control.  Summary of notifiable disease, United States, 1989 . MMWR Morb Motal Wkly Rep . 1988;37:54.
7.
Ostler HB.  Hansen's disease . Int Ophthalmol Clin . 1990;30:42-45.Article
8.
Trautman JR.  Epidemiologic aspects of Hansen's disease . Bull N Y Acad Med . 1984;60:722-731.
9.
Levis W, Schuman J, Friedman S.  An epidemiologic evaluation of leprosy in New York City . JAMA . 1982;247:3221-3226.Article
10.
Ridley DS, Jopling WH.  A classification of leprosy according to immunity: a five-group system . Int J Lepr Other Mycobact Dis . 1966;34:255-273.
11.
ffytche TJ.  Ocular leprosy: the continuing challenge . Int Ophthalmol . 1991;15:289-293.Article
12.
Espiritu CG, Gelber R, Ostler HB.  Chronic anterior uveitis in leprosy: an insidious cause of blindness . Br J Ophthalmol . 1991;75:273-275.Article
13.
Prendergast JJ.  Ocular leprosy in the United States: study of 350 cases . Arch Ophthalmol . 1940;23:112-137.Article
14.
Spaide R, Nattis R, Lipka A, D'Amico R.  Ocular findings in leprosy in the United States . Am J Ophthalmol . 1985;100:411-416.
15.
Schwab IR, Ostler HB, Dawson CR.  Ocular leprosy . In: Duane TD, Jaeger EA, eds. Clinical Ophthalmology . Philadelphia, Pa: JB Lippincott; 1988;5:3:1-8.
16.
Johnstone PA, George AD, Meyers WM.  Ocular lesions in leprosy . Ann Ophthalmol . 1991;23:297-303.
17.
Brandt F, Malla OK.  Ocular findings in leprous patients: a report of a survey in Malunga/Nepal . Grafes Arch Clin Exp Ophthalmol . 1981;217:27-34.Article
18.
Slem G.  Clinical studies of ocular leprosy . Am J Ophthalmol . 1971;71:431-434.
19.
Hogeweg M, Faber WR.  Progression of eye lesions in leprosy: ten-year follow-up study in the Netherlands . Int J Lepr . 1991;59:392-397.
20.
Weerekoon L.  Ocular leprosy in Ceylon . Br J Ophthalmol . 1969;53:457-465.Article
21.
Suryawanshi N.  Clinical manifestations of iridocyclitis in leprosy . Indian J Lepr . 1985;57:549-555.
22.
Cameron AN.  Leprosy and its ocular manifestations . Trans Ophthalmol Soc U K . 1961;81:637-640.
23.
Ffytche TJ.  Iritis in leprosy . Trans Ophthalmol Soc U K . 1981;101:325-327.
24.
Brand ME, ffytche TJ.  Eye complications of leprosy . In: Hastings RC, ed. Leprosy . New York, NY: Churchill Livingston Inc; 1985:223-242.
25.
Rajan MA.  Eye in multi-drug therapy . Indian J Lepr . 1990;62:33-38.
26.
Font RL, Sobol W, Matoba A.  Polychromatic corneal and conjunctival crystals secondary to clofazimine therapy in a leper . Ophthalmology . 1989;96:311-315.Article
27.
Courtright P, Lewallen S, Howe P.  Cell-mediated immunity in trachomatous scarring: evidence from a leprosy population . Ophthalmology . 1993;100:98-104.Article
28.
Courtright PD.  Defining the magnitude of ocular complications from leprosy: problems of methodology . Int J Lepr . 1988;56:566-573.
29.
Lamba PA, Santoshkumar D, Arthanariswaran R.  Ocular leprosy: a new perspective . Indian J Lepr . 1983;55:490-495.
×